NASDAQ:ADMS

Adamas Pharmaceuticals Earnings Date, Estimates & History

$5.26

+0.23 (+4.57 %)

(As of 03/2/2021 12:00 AM ET)

Add

Compare

Today's Range

$5.07

Now: $5.26▼

$5.54

50-Day Range

$4.46

MA: $5.37▼

$6.79

52-Week Range

$1.90

Now: $5.26▼

$9.15

Volume668,802 shs

Average Volume916,610 shs

Market Capitalization$160.79 million

P/E RatioN/A

Dividend YieldN/A

Beta2.96

Adamas Pharmaceuticals (NASDAQ:ADMS) Earnings Information

Adamas Pharmaceuticals last announced its quarterly earnings data on February 22nd, 2021. The specialty pharmaceutical company reported ($0.64) earnings per share for the quarter, missing the consensus estimate of ($0.53) by $0.11. Adamas Pharmaceuticals has generated ($3.80) earnings per share over the last year. Adamas Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 6th, 2021 based off prior year's report dates.

Adamas Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Adamas Pharmaceuticals (NASDAQ:ADMS) Earnings Estimates

2021 EPS Consensus Estimate: ($1.67)
2022 EPS Consensus Estimate: ($0.89)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2021	4	($0.57)	($0.45)	($0.53)
Q2 2021	4	($0.54)	($0.40)	($0.45)
Q3 2021	4	($0.52)	($0.31)	($0.40)
Q4 2021	3	($0.35)	($0.23)	($0.30)
Q1 2022	2	($0.40)	($0.28)	($0.34)
Q2 2022	2	($0.25)	($0.23)	($0.24)
Q3 2022	2	($0.19)	($0.18)	($0.19)
Q4 2022	2	($0.13)	($0.11)	($0.12)

Adamas Pharmaceuticals (NASDAQ ADMS) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Conference Call
5/6/2021 (Estimated)
2/22/2021	12/31/2020	($0.53)	($0.64)	($0.64)			Transcript
11/10/2020	9/30/2020	($0.48)	($0.42)	($0.42)	$21.37 million	$20.18 million	Listen
8/6/2020	6/30/2020	($0.61)	($0.37)	($0.37)	$15.63 million	$18.79 million	Transcript
5/7/2020	3/31/2020	($0.77)	($0.59)	($0.59)	$15.07 million	$14.48 million	Transcript
2/25/2020	Q4 2019	($0.89)	($0.8271)	($0.83)	$16.31 million	$16.35 million	Transcript
11/7/2019	9/30/2019	($0.90)	($0.99)	($0.99)	$14.36 million	$13.93 million	Transcript
8/8/2019	Q2 2019	($0.98)	($0.90)	($0.90)	$12.62 million	$12.69 million	N/A
5/9/2019	3/31/2019	($1.13)	($1.08)	($1.08)	$12.78 million	$11.67 million	N/A
3/4/2019	Q4	($1.36)	($1.06)	($1.06)	$13.30 million	$13.32 million	Transcript
11/1/2018	9/30/2018	($1.34)	($1.22)	($1.22)	$10.10 million	$10.61 million	Transcript

8/2/2018	Q2 2018	($1.41)	($1.2570)	($1.26)	$4.84 million	$7.57 million	N/A
5/3/2018	Q1 2018	($1.37)	($1.35)	($1.35)	$1.71 million	$2.55 million	N/A
2/22/2018	Q4 2017	($1.18)	($1.27)	($1.27)	$0.84 million	$0.57 million	N/A
11/2/2017	Q3 2017	($1.01)	($1.04)	($1.04)	$0.03 million		N/A
8/8/2017	Q2 2017	($0.81)	($0.93)	($0.93)	$0.03 million	$0.02 million	Listen
5/9/2017	Q1 2017	($0.72)	($0.72)	($0.72)	$0.11 million		Listen
2/28/2017	Q4	($0.80)	($0.68)	($0.68)	$0.17 million	$0.04 million	N/A
11/3/2016	Q3 2016	($0.83)	($0.66)	($0.66)	$0.26 million	$0.14 million	N/A
8/4/2016	Q2 2016	($0.71)	($0.78)	($0.78)	$0.18 million	$0.22 million	N/A
5/10/2016	Q1	($0.76)	($0.65)	($0.65)		$0.18 million	N/A
2/23/2016	Q4	($0.81)	($0.58)	($0.58)	$0.10 million	$0.52 million	N/A
11/12/2015	Q3	($0.79)	($0.81)	($0.81)	$0.10 million	$0.77 million	N/A
8/11/2015	Q215	($0.67)	($0.78)	($0.78)	$0.10 million	$0.40 million	N/A
5/13/2015	Q414	($0.74)	($0.69)	($0.69)	$0.10 million	$0.23 million	N/A
3/3/2015	Q4 2014	$0.64	$0.50	$0.50	$30.18 million	$30.30 million	N/A
11/4/2014	Q314	($0.44)	($0.57)	($0.57)	$0.18 million	$0.22 million	N/A
8/7/2014	Q214	$2.07	$0.88	$0.88	$18.75 million	$25.15 million	N/A
5/13/2014	Q114	($0.09)	($0.67)	($0.67)	$30.60 million	$0.18 million	Transcript

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 3/3/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Adamas Pharmaceuticals Earnings Date, Estimates & History

Adding

Adding

Adding Adamas Pharmaceuticals, Inc.

Earnings

Adamas Pharmaceuticals (NASDAQ:ADMS) Earnings Information

Adamas Pharmaceuticals Earnings Estimates and Actuals by Quarter

Adamas Pharmaceuticals (NASDAQ:ADMS) Earnings Estimates

Adamas Pharmaceuticals (NASDAQ ADMS) Earnings History by Quarter

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources